Nagane M - Search Results

1

Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor.

Nagane M, Narita Y, Mishima K, Levitzki A, Burgess AW, Cavenee WK, Huang HJ. Nagane M, et al. J Neurosurg. 2001 Sep;95(3):472-9. doi: 10.3171/jns.2001.95.3.0472. J Neurosurg. 2001. PMID: 11565870

2

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.

Cheng SY, Huang HJ, Nagane M, Ji XD, Wang D, Shih CC, Arap W, Huang CM, Cavenee WK. Cheng SY, et al. Among authors: nagane m. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8502-7. doi: 10.1073/pnas.93.16.8502. Proc Natl Acad Sci U S A. 1996. PMID: 8710899 Free PMC article.

3

Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway.

Prigent SA, Nagane M, Lin H, Huvar I, Boss GR, Feramisco JR, Cavenee WK, Huang HS. Prigent SA, et al. Among authors: nagane m. J Biol Chem. 1996 Oct 11;271(41):25639-45. doi: 10.1074/jbc.271.41.25639. J Biol Chem. 1996. PMID: 8810340 Free article.

4

A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.

Nagane M, Coufal F, Lin H, Bögler O, Cavenee WK, Huang HJ. Nagane M, et al. Cancer Res. 1996 Nov 1;56(21):5079-86. Cancer Res. 1996. PMID: 8895767

5

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.

Huang HS, Nagane M, Klingbeil CK, Lin H, Nishikawa R, Ji XD, Huang CM, Gill GN, Wiley HS, Cavenee WK. Huang HS, et al. Among authors: nagane m. J Biol Chem. 1997 Jan 31;272(5):2927-35. doi: 10.1074/jbc.272.5.2927. J Biol Chem. 1997. PMID: 9006938 Free article.

6

Advances in the molecular genetics of gliomas.

Nagane M, Huang HJ, Cavenee WK. Nagane M, et al. Curr Opin Oncol. 1997 May;9(3):215-22. doi: 10.1097/00001622-199709030-00001. Curr Opin Oncol. 1997. PMID: 9229142 Review.

7

Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189.

Cheng SY, Nagane M, Huang HS, Cavenee WK. Cheng SY, et al. Among authors: nagane m. Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12081-7. doi: 10.1073/pnas.94.22.12081. Proc Natl Acad Sci U S A. 1997. PMID: 9342366 Free PMC article.

8

Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.

Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJ. Nagane M, et al. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5724-9. doi: 10.1073/pnas.95.10.5724. Proc Natl Acad Sci U S A. 1998. PMID: 9576951 Free PMC article.

9

Host microvasculature influence on tumor vascular morphology and endothelial gene expression.

Roberts WG, Delaat J, Nagane M, Huang S, Cavenee WK, Palade GE. Roberts WG, et al. Among authors: nagane m. Am J Pathol. 1998 Oct;153(4):1239-48. doi: 10.1016/S0002-9440(10)65668-4. Am J Pathol. 1998. PMID: 9777955 Free PMC article.

10

Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.

Bögler O, Nagane M, Gillis J, Huang HJ, Cavenee WK. Bögler O, et al. Among authors: nagane m. Cell Growth Differ. 1999 Feb;10(2):73-86. Cell Growth Differ. 1999. PMID: 10074901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page